David Robertson

David Robertson, MD, second from left, poses with three longtime colleagues who spoke during last week’s symposium honoring his scientific legacy. Read More

David Robertson, MD, internationally known for his groundbreaking work in defining and treating often-debilitating neurological disorders of blood pressure regulation, will be honored with a two-day symposium May 3-4 at Langford Auditorium. Read More

When David Robertson, MD, sorted through 39 years’ worth of textbooks, journals and framed photographs in Vanderbilt University Medical Center’s (VUMC) Clinical Research Center (CRC) recently as he prepared for retirement, the memory that brought him to tears was a 30-year-old embroidery piece by his daughter, Rose Robertson Pink. Read More

Kevin Niswender, MD, PhD, whose work has helped advance understanding of the neural underpinnings of obesity and metabolic syndrome, has been named director of the Clinical Research Center (CRC) at Vanderbilt University Medical Center (VUMC). Read More

Vanderbilt’s David Robertson, M.D., and Meena Madhur, M.D., Ph.D., were recognized by the American Heart Association’s Council on Hypertension during the annual Council on Hypertension Scientific Sessions meeting in Orlando this week. Read More

A nationwide research group headed by Vanderbilt University’s David Robertson, M.D., has received another round of funding from the federal government to continue studies of rare neurodegenerative diseases and disorders affecting blood pressure. Read More

Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read More

Vanderbilt University’s largest single government research grant, its Clinical and Translational Science Award (CTSA), has been renewed for another five years for $46 million. Read More